Valiant Co

Valiant Co Stock-Based Compensation

The Stock-Based Compensation (SBC) of Valiant Co (002643.SZ) as of Nov 19, 2026 is 70.75 M CNY. In the previous year, Stock-Based Compensation (SBC) was 41.04 M CNY — a change of 72.40% (higher).

Stock-Based Compensation

70.75 MCNY

YoY

72.40%

Last updated:

Stock-Based Compensation (SBC) of Valiant Co is 2023 70.75 M CNY. Stock-Based Compensation (SBC) of Valiant Co was 2022 41.04 M CNY. It decreases by 72.40% higher compared to the previous year.

The Valiant Co Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2021
13.76 M CNY
Jan 1, 2022
41.04 M CNY
Jan 1, 2023
70.75 M CNY
The Valiant Co Stock-Based Compensation history
YEARStock-Based CompensationYoY
70.75 MCNY+72.40%
41.04 MCNY+198.30%
13.76 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Co Stock analysis

What does Valiant Co do? Valiant Co., Ltd. generates revenue through three core business segments. The Information Materials Industry segment produces and sells display materials and functional materials, targeting customers in the electronics and manufacturing sectors. The Environmental Protection Materials Industry segment develops and manufactures new zeolite environmental protection materials for tail gas purification, serving automotive and industrial clients requiring emission control solutions. The Large Health Industry segment focuses on pharmaceutical production, life sciences, and in vitro diagnostic services, catering to healthcare providers and medical facilities. The company's products include display materials, functional materials, new zeolite environmental protection materials, pharmaceuticals, and in vitro diagnostic services. These offerings are sold across the three industry segments, with the Environmental Protection Materials segment specifically addressing tail gas purification needs. The Large Health Industry segment's in vitro diagnostic services support healthcare operations through specialized medical solutions. Valiant Co., Ltd. serves diverse customer segments including electronics manufacturers, automotive industries, industrial emission control clients, and healthcare providers. The firm's revenue streams are derived from the sale of physical products like display materials and zeolite materials, as well as service-based offerings in diagnostics and pharmaceuticals. The company's business model relies on manufacturing and selling these products across its three operational segments. Valiant Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Co stock

Stock-Based Compensation (SBC) of Valiant Co is 70.75 M CNY in 2023.

Stock-Based Compensation (SBC) of Valiant Co changed from 41.04 M CNY to 70.75 M CNY, representing a 72.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Valiant Co since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Valiant Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Valiant Co

All Key Metrics — Valiant Co